Chantal (Dubien) Bidal is a seasoned professional in the pharmaceutical and clinical research sectors, currently serving as Senior Director at Pfizer since January 2024. Prior experience includes serving as Director in Late Stage Oncology at Seagen from November 2020 to March 2024 and holding various positions at Merck from 2010 to 2020, including Clinical Scientist and Associate Director of RCPM. Chantal has also worked as Clinical Operations Manager at Concordia Healthcare Corp., Senior CRA and CRA at Schering-Plough Research Institute, and Manager of Multiple Sclerosis Research at St. Michael's Hospital. Chantal earned a degree from Laurentian University/Université Laurentienne between 1998 and 2002.
This person is not in any teams
This person is not in any offices